Chinese Covid-19 vaccine V-01 enters phase-III trials in Philippines


An employee works at the Covid-19 vaccine trial production workshop at Livzon Pharmaceutical Group Inc in south China's Guangdong Province. - Xinhua

GUANGZHOU, Aug 30 (Xinhua): A recombinant Covid-19 fusion protein vaccine (V-01) developed and manufactured in China has been approved for phase-III clinical trials in the Philippines.

The V-01 vaccine was developed by the Institute of Biophysics under the Chinese Academy of Sciences and Livzon Pharmaceutical Group Inc. (LivzonBio) in south China's Guangdong Province.

Subscribe now for a chance to win your dream holiday!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Aseanplus News

Asean news headlines as at 10pm on Friday (July 19)
Cebu Pacific, AirAsia hit by Microsoft global outage
K-drama star Lee Joon Gi in KL this September
Chinese envoy celebrates opening of Jinping Boulevard, highlights strong Sino-Cambodian ties
'I'm a guy, I'm an idiot': Harith Iskander blames himself for pending divorce
Myanmar marks 77th anniversary of the assassination of independence hero Gen Aung San
High Court rejects Iswaran’s bid for prosecution to provide statements of witnesses; trial set for Aug 13
Microsoft outage hits some Philippine banks
Bakong mobile payment system to facilitate international tourist spending
Microsoft system disruption causes flight check-in delays in Vietnam

Others Also Read